Table 1 Biological characteristics of primary DLBCL patients
Patient | Age | Sex | Type | Disease status | Previous treatment | TP53 status | BCL6 | BCL2 | c-MYC | CD20 | CD10 | Ki67 (%) | MUM-1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 63 | M | ABC-DLBCL | D | NO | mut | NS | + | NS | + | − | 40–50 | − |
2 | 45 | M | GCB-DLBCL | D | NO | mut | + | −/+ | + | + | + | 95 | + |
3 | 55 | F | ABC-DLBCL | D | NO | mut | − | − | − | + | − | 37.2 | − |
4 | 53 | F | ABC-DLBCL | D | NO | mut | − | + | − | + | − | 60 | − |
5 | 53 | F | ABC-DLBCL | D | NO | del/wt | − | + | − | + | − | 50 | + |
6 | 68 | M | ABC-DLBCL | D | NO | mut | + | + | − | + | − | 60 | + |
7 | 85 | F | GCB-DLBCL | D | NO | wt | + | + | − | + | − | 40 | − |
8 | 57 | M | GCB-DLBCL | D | NO | del/wt | − | − | − | + | − | 70 | − |